Ultragenyx Pharmaceutical Inc. <RARE.O>: Baird cuts to neutral rating; cuts target price to $16 from $40
RARE•Related News
CenterPoint Energy <CNP.N>: RBC Initiates Coverage With Sector Perform Rating; Target Price $40
CNP•
Guardant Health CIO Kumud Kalia disposes of 4,000 common shares worth $632,193.20
GH•
JGB yields rise on government spending worries, with eyes on cabinet reshuffle
TLT•
GRAINS-Wheat dips on Black Sea de-escalation hopes; soy, corn firm
DBA•
Trump's Ukraine energy truce won't fix global diesel crunch: Bousso
XLE•